DMK
LGND icon

David M. Knott’s Ligand Pharmaceuticals LGND Stock Holding History

David M. Knott’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$10.4M Hold
120,225
– – 3.8% 6
2021
Q2 		$9.84M Hold
120,225
– – 3.5% 7
2021
Q1 		$11.4M Sell
120,225
-277,385
-70% -$26.2M 4.89% 6
2020
Q4 		$24.7M Hold
397,610
– – 11.16% 1
2020
Q3 		$23.6M Sell
397,610
-40,075
-9% -$2.73M 13.87% 1
2020
Q2 		$30.5M Sell
437,685
-128,240
-23% -$8.13M 16.67% 1
2020
Q1 		$25.7M Hold
565,925
– – 16.2% 1
2019
Q4 		$36.8M Hold
565,925
– – 14.92% 1
2019
Q3 		$35.1M Hold
565,925
– – 14.76% 1
2019
Q2 		$40.3M Buy
565,925
+14,427
+3% +$1.06M 17% 1
2019
Q1 		$43.3M Hold
551,498
– – 17.24% 1
2018
Q4 		$46.7M Hold
551,498
– – 21.94% 1
2018
Q3 		$94.4M Hold
551,498
– – 30.64% 1
2018
Q2 		$71.3M Sell
551,498
-335,027
-38% -$37.4M 26.72% 1
2018
Q1 		$91.3M Sell
886,525
-336,474
-28% -$33.3M 37.65% 1
2017
Q4 		$104M Sell
1,222,999
-56,355
-4% -$4.88M 41.55% 1
2017
Q3 		$109M Sell
1,279,354
-320,600
-20% -$25.4M 46.45% 1
2017
Q2 		$121M Hold
1,599,954
– – 50.58% 1
2017
Q1 		$106M Hold
1,599,954
– – 50.83% 1
2016
Q4 		$101M Hold
1,599,954
– – 51.04% 1
2016
Q3 		$102M Sell
1,599,954
-323,271
-17% -$23.7M 52.58% 1
2016
Q2 		$143M Hold
1,923,225
– – 32.96% 1
2016
Q1 		$128M Hold
1,923,225
– – 34.23% 1
2015
Q4 		$130M Hold
1,923,225
– – 35.65% 1
2015
Q3 		$103M Sell
1,923,225
-80,150
-4% -$4.86M 29.64% 1
2015
Q2 		$126M Hold
2,003,375
– – 26.09% 1
2015
Q1 		$96.4M Hold
2,003,375
– – 20.76% 1
2014
Q4 		$66.5M Hold
2,003,375
– – 15.68% 1
2014
Q3 		$58.7M Hold
2,003,375
– – 11.17% 1
2014
Q2 		$77.8M Hold
2,003,375
– – 13.96% 1
2014
Q1 		$84.1M Sell
2,003,375
-68,608
-3% -$2.86M 16.07% 1
2013
Q4 		$68M Hold
2,071,983
– – 13.87% 1
2013
Q3 		$55.9M Sell
2,071,983
-256,480
-11% -$7.22M 10.7% 1
2013
Q2 		$54.3M Buy
+2,328,463
New +$41.9M 11.3% 1

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

David M. Knott's LGND Position: Q3 2021 in Review

David M. Knott held its Ligand Pharmaceuticals (LGND) position steady in Q3 2021 at 120,225 shares worth $10.4M. The position accounts for 3.8% of the portfolio, ranked #6.

David M. Knott first reported a position in LGND in Q2 2013 and has held it in 34 quarters since. The position peaked at $143M in Q2 2016. 207 funds tracked by Wall St. Rank hold LGND as of Q3 2021.

  • David M. Knott held 120,225 shares of Ligand Pharmaceuticals worth $10.4M as of Q3 2021.
  • David M. Knott left its Ligand Pharmaceuticals share count unchanged in Q3 2021.
  • Ligand Pharmaceuticals made up 3.8% of David M. Knott's portfolio in Q3 2021, its #6 holding.
  • David M. Knott first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 34 quarters since.
  • David M. Knott's Ligand Pharmaceuticals position peaked at $143M in Q2 2016.
  • 207 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2021.

Based on David M. Knott's 13F filing for Q3 2021, filed 12 Nov 2021.